Loading...
Healthcare And Defense Materials Will Steadily Support A Fairly Valued Long Term Outlook
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
10 Jan 26
Views
13
10 Jan
US$35.29
AnalystLowTarget's Fair Value
US$34.00
3.8% overvalued intrinsic discount1Y
-5.3%7D
8.1%1Y
-5.3%7D
8.1%You can edit this narrative until Jan 11 1:05 PM. Then, changes will post as Updates.
Author's Valuation
US$343.8% overvalued intrinsic discount
AnalystLowTarget Fair Value